Skip to content
TrackPodcasts
businessOct 20, 202140:02pending

Paul Tudor Jones: “Crypto is clearly winning”

Squawk Pod

About this episode

Shares of Novavax are down sharply after Politico reported the company is having problems manufacturing its highly anticipated Covid-19 vaccine. Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, discusses Covid therapeutics, vaccines, and the U.S. production and manufacturing system. Paul Tudor Jones, founder and CIO at Tudor Investment Corporation and founder of the Robin Hood Foundation, shares his inflation trades and portfolio breakdown. The legendary hedge fund manager also explains which assets investors should stay away from as the Federal Reserve slowly reacts to rising prices. New York City has announced an expansion of its Covid vaccine mandate to all public employees, removing the option to test out. Plus, Facebook may soon be rebranded with a new name.

In this episode:
Dr. Scott Gottlieb, @ScottGottliebMD
Paul Tudor Jones, @ptj_official
Becky Quick, @BeckyQuick

Andrew Ross Sorkin, @andrewrsorkin


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Get every episode summarized

Each time Squawk Pod publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

Paul Tudor Jones: “Crypto is clearly winning”

Squawk Pod

0:00
40:02

More episodes

More from Squawk Pod

View all episodes →